Pulse Biosciences, Inc.
DE ˙ DB ˙ US74587B1017
20,20 € ↓ -1,20 (-5,61%)
2026-06-05
DEL PRIS
SecurityDE:6L8 / Pulse Biosciences, Inc.
InstitutionGoldman Sachs Group Inc
Latest Disclosed Ownership28,711 shares
Latest Disclosed Value $ 619,870
Goldman Sachs Group Inc reports 27.87% increase in ownership of 6L8 / Pulse Biosciences, Inc.

On May 15, 2026 - Goldman Sachs Group Inc filed a 13F-HR form disclosing ownership of 28,711 shares of Pulse Biosciences, Inc. (DE:6L8) valued at $490,958 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 22,453 shares of Pulse Biosciences, Inc.. This represents a change in shares of 27.87% during the quarter. The current value of the position is $579,962 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F PULSE BIOSCIENCES CMN 74587B101 28,711 6,258 27.87 620 100.97 0.0000
2026-02-10 2025-12-31 13F PULSE BIOSCIENCES CMN 74587B101 22,453 5,322 31.07 308 1.65 0.0000
2025-11-14 2025-09-30 13F PULSE BIOSCIENCES CMN 74587B101 17,131 5,546 47.87 303 74.14 0.0000
2025-08-14 2025-06-30 13F PULSE BIOSCIENCES CMN 74587B101 11,585 -27,462 -70.33 175 -72.29 0.0000
2025-06-27 2025-03-31 13F/A-2 PULSE BIOSCIENCES CMN 74587B101 39,047 -11,208 -22.30 628 -28.15 0.0001
2025-05-16 2025-03-31 13F/A-1 PULSE BIOSCIENCES CMN 74587B101 39,047 -11,208 628 0.0001
2025-05-09 2025-03-31 13F PULSE BIOSCIENCES CMN 74587B101 39,047 -11,208 628 0.0000
2025-02-11 2024-12-31 13F PULSE BIOSCIENCES CMN 74587B101 50,255 14,560 40.79 875 39.62 0.0001
2024-11-14 2024-09-30 13F PULSE BIOSCIENCES CMN 74587B101 35,695 35,695 626 0.0001
2024-08-13 2024-06-30 13F PULSE BIOSCIENCES CMN 74587B101 0 -12,206 -100.00 0 -100.00
2024-05-15 2024-03-31 13F PULSE BIOSCIENCES CMN 74587B101 12,206 12,206 106 0.0000
2024-05-15 2023-09-30 13F/A-1 PULSE BIOSCIENCES CMN 74587B101 0 -10,279 -100.00 0 -100.00
2023-11-14 2023-09-30 13F PULSE BIOSCIENCES CMN 74587B101 0 -10,279 0
2024-05-14 2023-06-30 13F/A-1 PULSE BIOSCIENCES CMN 74587B101 10,279 10,279 74 0.0000
2023-08-15 2023-06-30 13F PULSE BIOSCIENCES CMN 74587B101 10,279 10,279 74 0.0000
2024-05-14 2022-09-30 13F/A-1 PULSE BIOSCIENCES CMN 74587B101 0 -12,173 -100.00 0 0.0000
2022-11-10 2022-09-30 13F PULSE BIOSCIENCES CMN 74587B101 0 -12,173 0 0.0000
2024-05-14 2022-06-30 13F/A-2 PULSE BIOSCIENCES CMN 74587B101 12,173 -3,622 -22.93 0 -100.00 0.0000
2022-08-18 2022-06-30 13F/A-1 PULSE BIOSCIENCES CMN 74587B101 12,173 -3,622 19 0.0000
2022-08-15 2022-06-30 13F PULSE BIOSCIENCES CMN 74587B101 12,173 -3,622 19 0.0000
2022-05-16 2022-03-31 13F PULSE BIOSCIENCES CMN 74587B101 15,795 3,273 26.14 77 -58.38 0.0000
2022-02-17 2021-12-31 13F/A-1 PULSE BIOSCIENCES CMN 74587B101 12,522 66 0.53 185 -31.23 0.0000
2022-02-14 2021-12-31 13F PULSE BIOSCIENCES CMN 74587B101 12,522 66 185 0.0000
2022-01-20 2021-09-30 13F/A-1 PULSE BIOSCIENCES CMN 74587B101 12,456 1,244 11.10 269 46.20 0.0001
2021-11-10 2021-09-30 13F PULSE BIOSCIENCES CMN 74587B101 12,456 1,244 269 0.0001
2021-08-13 2021-06-30 13F PULSE BIOSCIENCES CMN 74587B101 11,212 -10,409 -48.14 184 -64.06 0.0000
2021-05-17 2021-03-31 13F PULSE BIOSCIENCES CMN 74587B101 21,621 12,664 141.39 512 139.25 0.0001
2021-02-12 2020-12-31 13F PULSE BIOSCIENCES CMN 74587B101 8,957 8,957 214 0.0001
2018-02-14 2017-12-31 13F PULSE BIOSCIENCES CMN 74587B101 0 -20,761 -100.00 0 -100.00
2017-11-14 2017-09-30 13F PULSE BIOSCIENCES CMN 74587B101 20,761 2,646 14.61 386 -38.34 0.0001
2017-08-14 2017-06-30 13F PULSE BIOSCIENCES CMN 74587B101 18,115 -4,868 -21.18 626 33.48 0.0002
2017-05-18 2017-03-31 13F/A-1 PULSE BIOSCIENCES CMN 74587B101 22,983 -19,898 -46.40 469 68.10 0.0001
2017-05-15 2017-03-31 13F PULSE BIOSCIENCES CMN 74587B101 22,983 469
2017-02-14 2016-12-31 13F PULSE BIOSCIENCES CMN 74587B101 42,881 -9,187 -17.64 279 -14.94 0.0001
2016-11-14 2016-09-30 13F PULSE BIOSCIENCES CMN 74587B101 52,068 27,068 108.27 328 192.86 0.0001
2016-08-15 2016-06-30 13F PULSE BIOSCIENCES CMN 74587B101 25,000 25,000 112 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.